Oxaliplatin Injection, Solution
Product Images NDC 72266-162

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 72266-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxaliplatin-10ml-ctn (Oxaliplatin 10ml Ctn)

Oxaliplatin Injection USP 50 mg/10 mL (5 mg/mL) single-dose vial carton label by Fosun Pharma USA Inc. The label states it is a sterile aqueous, preservative-free solution for intravenous use only, marked as a cytotoxic agent with warnings not to mix with sodium chloride or chloride-containing solutions. Storage instructions indicate to keep between 20° to 25°C and protect from light, with discarded unused portions guidance. The product is made in India and distributed by Fosun Pharma USA.*

FDA Label Image

Oxaliplatin-10ml-lbl (Oxaliplatin 10ml Lbl)

Label for Oxaliplatin Injection, USP 50 mg/10 mL (5 mg/mL) single-dose vial. The label states it is for intravenous use only, a cytotoxic agent with a warning not to mix with sodium chloride/chloride-containing solutions. Distributed by Fosun Pharma USA Inc., made in India, with storage and usage instructions.*

FDA Label Image

Oxaliplatin-20ml-ctn (Oxaliplatin 20ml Ctn)

Oxaliplatin Injection, USP 100 mg/20 mL (5 mg/mL) carton label for intravenous use. The label indicates it is a cytotoxic agent, sterile aqueous solution, preservative free, with storage instructions between 20°C and 25°C and warnings against mixing with sodium chloride solutions. Distributed by Fosun Pharma USA Inc.*

FDA Label Image

Oxaliplatin-20ml-lbl (Oxaliplatin 20ml Lbl)

Label for Oxaliplatin Injection, USP, 100 mg/20 mL (5 mg/mL) single-dose vial by Fosun Pharma USA Inc. The label indicates intravenous use only and includes warnings not to mix with sodium chloride-containing solutions. It specifies sterile aqueous solution, storage instructions, and manufacturing details from India.*

FDA Label Image

Oxaliplatin Spl Figure 01

This image is a line graph depicting disease-free survival (DFS) probability over time in months. It compares two treatment arms: FOLFOX4 and LV5FU2, with the FOLFOX4 arm showing a higher survival probability across months. The graph includes a legend with number of events and hazard ratio data, as well as patient numbers at risk at various time points.*

FDA Label Image

Oxaliplatin Spl Figure 02

A Kaplan-Meier survival curve chart showing disease-free survival (DFS) probability over time in months for two treatment arms: FOLFOX4 versus LV5FU2, both compared to DUKES C. The chart includes a hazard ratio for Stage III with confidence intervals and a p-value from a Logrank test, illustrating differences in DFS between treatment groups.*

FDA Label Image

Oxaliplatin Spl Figure 03

A Kaplan-Meier survival curve chart depicting the percentage of patients surviving over 24 months. The chart compares three treatment groups: oxaliplatin plus 5-FU/LV, oxaliplatin plus irinotecan, and irinotecan plus 5-FU/LV, with median survival times of 19.4, 17.6, and 14.6 months respectively. A p-value of less than 0.0001 is noted, indicating statistical significance.*

FDA Label Image

Oxaliplatin Spl Structure

Chemical structure diagram of Oxaliplatin showing its molecular arrangement with platinum (Pt) coordinated to amine groups and oxalate ligands.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.